{"id":"https://openalex.org/W2062768595","doi":"https://doi.org/10.4088/jcp.12m08160","title":"The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial","display_name":"The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial","alternate_titles":[],"publication_year":2013,"publication_date":"2013-12-15","ids":{"openalex":"https://openalex.org/W2062768595","doi":"https://doi.org/10.4088/jcp.12m08160","mag":"2062768595","pmid":"https://pubmed.ncbi.nlm.nih.gov/24434091"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.12m08160","doi":"https://doi.org/10.4088/jcp.12m08160","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.12m08160","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2062768595"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059532230","display_name":"Vladimir Lerner","orcid":"https://orcid.org/0000-0002-2643-7302","observed_orcids":["https://orcid.org/0000-0002-2643-7302"]},"institutions":[{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vladimir Lerner","raw_affiliation_strings":["Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychiatry, Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva","institution_ids":["https://openalex.org/I124227911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017864703","display_name":"Chanoch Miodownik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chanoch Miodownik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028436352","display_name":"Anatoly Gibel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anatoly Gibel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111787131","display_name":"Pinchas Sirota","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pinchas Sirota","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042168845","display_name":"Ilan Bush","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ilan Bush","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Hadi Elliot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hadi Elliot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110236248","display_name":"R. Benatov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ruben Benatov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113536965","display_name":"Michael S. Ritsner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael S. Ritsner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113536965"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5617,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88324213,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"74","issue":"12","first_page":"1224","last_page":"1232"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bexarotene","display_name":"bexarotene","score":0.9990000128746033},{"id":"https://openalex.org/keywords/retinoid-x-receptor-agonist","display_name":"retinoid X receptor agonist","score":0.9570000171661377},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":1.0},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.972000002861023},{"id":"https://openalex.org/keywords/antipsychotic-augmentation","display_name":"antipsychotic augmentation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cholesterol","display_name":"cholesterol","score":0.8550000190734863},{"id":"https://openalex.org/keywords/thyroxine","display_name":"thyroxine","score":0.8830000162124634},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5180000066757202},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.6069999933242798},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8130000233650208},{"id":"https://openalex.org/keywords/functioning","display_name":"functioning","score":0.5479999780654907},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.6010000109672546},{"id":"https://openalex.org/keywords/nuclear-receptor-signaling","display_name":"nuclear receptor signaling","score":0.42100000381469727},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C2778820923","wikidata":"https://www.wikidata.org/wiki/Q418192","display_name":"Bexarotene","level":5,"score":0.8997843861579895},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.8659946918487549},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6803804636001587},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6416375041007996},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.550902783870697},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5180042386054993},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.5091974139213562},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5067024827003479},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.46996399760246277},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4395201504230499},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3828386068344116},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35201817750930786},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06711530685424805},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.047385841608047485},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000077610","descriptor_name":"Bexarotene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013764","descriptor_name":"Tetrahydronaphthalenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013764","descriptor_name":"Tetrahydronaphthalenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039721","descriptor_name":"Diagnostic and Statistical Manual of Mental Disorders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047488","descriptor_name":"Retinoid X Receptors","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.12m08160","doi":"https://doi.org/10.4088/jcp.12m08160","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.12m08160","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:24434091","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24434091","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W16691718","https://openalex.org/W44771556","https://openalex.org/W115487351","https://openalex.org/W174661090","https://openalex.org/W238363503","https://openalex.org/W1899283284","https://openalex.org/W1927684145","https://openalex.org/W1949170239","https://openalex.org/W1963580478","https://openalex.org/W1965266307","https://openalex.org/W1974283351","https://openalex.org/W1976405146","https://openalex.org/W1976790158","https://openalex.org/W1979887383","https://openalex.org/W1984216694","https://openalex.org/W1988329373","https://openalex.org/W1993446055","https://openalex.org/W1994686928","https://openalex.org/W1999170657","https://openalex.org/W1999689270","https://openalex.org/W2001515160","https://openalex.org/W2003580658","https://openalex.org/W2012863812","https://openalex.org/W2014250215","https://openalex.org/W2014736356","https://openalex.org/W2020626851","https://openalex.org/W2021330953","https://openalex.org/W2022320465","https://openalex.org/W2023052292","https://openalex.org/W2037124948","https://openalex.org/W2037259928","https://openalex.org/W2039786436","https://openalex.org/W2050519369","https://openalex.org/W2055491924","https://openalex.org/W2057339543","https://openalex.org/W2081388499","https://openalex.org/W2082246284","https://openalex.org/W2087822238","https://openalex.org/W2089938835","https://openalex.org/W2094117647","https://openalex.org/W2098636860","https://openalex.org/W2105486770","https://openalex.org/W2107031757","https://openalex.org/W2114987540","https://openalex.org/W2116265043","https://openalex.org/W2119137992","https://openalex.org/W2125577585","https://openalex.org/W2133639929","https://openalex.org/W2140606211","https://openalex.org/W2141414208","https://openalex.org/W2142161937","https://openalex.org/W2151331628","https://openalex.org/W2153647448","https://openalex.org/W2171122740","https://openalex.org/W2172184136","https://openalex.org/W3090293687"],"related_works":["https://openalex.org/W2014736356","https://openalex.org/W4205284823","https://openalex.org/W2296085137","https://openalex.org/W1996796264","https://openalex.org/W2271539669","https://openalex.org/W3139610025","https://openalex.org/W2133447633","https://openalex.org/W4412508899","https://openalex.org/W2323627339","https://openalex.org/W3193660642"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,23,108,290],"limitations":[2],"of":[3,15,19,43,56,63,113,133,219,287,295,298],"antipsychotic":[4,61,100,148],"therapy":[5],"in":[6,40,85,110,254,264],"schizophrenia":[7,44,66,80],"and":[8,45,54,73,118,135,208,230,261,293],"schizoaffective":[9,46,68,82],"disorder":[10,83],"led":[11],"to":[12,51,59,98,105,168],"the":[13,16,41,111,116,144,285],"investigation":[14],"putative":[17],"utility":[18],"pharmacologic":[20],"augmentation":[21],"strategies.":[22],"antitumor":[24],"agent":[25],"bexarotene":[26,58,159,299],"via":[27],"nuclear":[28],"retinoid":[29],"X":[30],"receptor":[31],"(RXR)":[32],"activation":[33],"might":[34,273],"modulate":[35],"numerous":[36],"metabolic":[37],"pathways":[38],"involved":[39],"pathogenesis":[42],"disorder.":[47,69],"This":[48],"trial":[49],"aimed":[50],"investigate":[52],"efficacy":[53],"safety":[55],"add-on":[57],"ongoing":[60,99,296],"treatment":[62,101,179],"patients":[64,155,169,209],"with":[65,189,199],"or":[67,81,201],"METHOD:":[70],"Ninety":[71],"inpatients":[72],"outpatients":[74],"that":[75,154],"met":[76],"DSM-IV-TR":[77],"criteria":[78],"for":[79,147,281,284],"participated":[84],"a":[86,124,150,251,262,276],"6-week,":[87],"double-blind,":[88],"randomized,":[89],"placebo-controlled":[90],"multicenter":[91],"study.":[92],"Bexarotene":[93,240,272],"(75":[94],"mg/d)":[95],"was":[96,123,241],"added":[97],"from":[102],"October":[103],"2008":[104],"December":[106],"2010.":[107],"reduction":[109,286],"severity":[112],"symptoms":[114,221,229],"on":[115],"Positive":[117],"Negative":[119],"Syndrome":[120],"Scale":[121],"(PANSS)":[122],"primary":[125],"outcome.":[126],"Secondary":[127],"outcomes":[128],"included":[129],"general":[130],"functioning,":[131],"quality":[132],"life,":[134],"side":[136,247],"effect":[137,191],"scales.":[138],"RESULTS:":[139],"Seventy-nine":[140],"participants":[141],"(88%)":[142],"completed":[143],"protocol.":[145],"Controlling":[146],"agents,":[149],"mixed":[151],"model":[152],"showed":[153],"who":[156,170,210],"received":[157,171],"adjunctive":[158,238],"had":[160],"significantly":[161],"lower":[162],"PANSS":[163,204],"positive":[164,205,220,288],"scale":[165,206],"scores":[166,207],"compared":[167],"placebo":[172],"(F":[173,222],"=":[174,177,184,187,194,223,226],"8.6,":[175],"P":[176,186,225],".003;":[178],"arms":[180],"\u00d7":[181],"time,":[182],"F":[183],"2.7,":[185],".049),":[188],"moderate":[190],"size":[192],"(d":[193],"0.48;":[195],"95%":[196],"CI,0.04-0.93).":[197],"Patients":[198],"mean":[200],"higher":[202],"baseline":[203],"did":[211],"not":[212,235],"take":[213],"lipid-reducing":[214],"agents":[215],"revealed":[216],"greater":[217],"amelioration":[218],"7.4,":[224],".008).":[227],"Other":[228],"secondary":[231],"outcome":[232],"measures":[233],"were":[234,249],"affected":[236],"by":[237],"bexarotene.":[239],"well":[242],"tolerated,":[243],"though":[244],"2":[245],"reversible":[246],"effects":[248],"reported:":[250],"significant":[252],"increase":[253],"total":[255,265],"cholesterol":[256],"levels":[257,267],"(P":[258,268],"<":[259,269],".001)":[260],"decrease":[263],"thyroxine":[266],".001).":[270],"CONCLUSIONS:":[271],"potentially":[274],"be":[275],"novel":[277],"adjuvant":[278],"therapeutic":[279],"strategy":[280],"schizophrenia,":[282],"particularly":[283],"symptoms.":[289],"potential":[291],"benefits":[292],"risks":[294],"administration":[297],"warrant":[300],"further":[301],"evaluation.":[302],"TRIAL":[303],"REGISTRATION:":[304],"ClinicalTrials.gov":[305],"identifier:":[306],"NCT00535574.":[307]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2062768595","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
